4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001920738-26-000002
Chief Legal Officer sold 9,810 shares at $12.00 ($117,720)
- Chief Legal Officer acquired 9,810 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2026-06-23 | Option exercise 10b5-1 | +9,810 | $4.14 | $40,613 | 18,427 | D |
| Bizily Scott Chief Legal Officer | 2026-06-23 | Sale 10b5-1 | −9,810 | $12.00 | $117,720 | 8,617 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2026-06-23 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,810 | 63,785 | D | ||
| Open-market sales · 9,810 sh · avg $12.00 · $117,720 | |||||||
Loading xslF345X06/ownership.xml…